statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	3.824
EU - Europa	3.466
AS - Asia	2.542
SA - Sud America	385
AF - Africa	50
OC - Oceania	10
Continente sconosciuto - Info sul continente non disponibili	2
Totale	10.279

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	3.677
IT - Italia	2.236
SG - Singapore	1.304
HK - Hong Kong	498
CN - Cina	356
BR - Brasile	343
GB - Regno Unito	265
DE - Germania	181
RU - Federazione Russa	173
IE - Irlanda	154
VN - Vietnam	100
UA - Ucraina	89
CA - Canada	85
FI - Finlandia	83
IN - India	74
TR - Turchia	74
SE - Svezia	69
MX - Messico	49
JP - Giappone	39
AT - Austria	38
FR - Francia	38
PL - Polonia	35
BD - Bangladesh	25
NL - Olanda	25
ES - Italia	22
ZA - Sudafrica	22
LT - Lituania	18
AR - Argentina	17
BE - Belgio	17
IQ - Iraq	16
AE - Emirati Arabi Uniti	10
CH - Svizzera	9
AU - Australia	8
EC - Ecuador	7
SA - Arabia Saudita	7
CL - Cile	5
EG - Egitto	5
ID - Indonesia	5
KE - Kenya	5
MA - Marocco	5
MY - Malesia	5
TN - Tunisia	5
CO - Colombia	4
JO - Giordania	4
VE - Venezuela	4
BB - Barbados	3
CI - Costa d'Avorio	3
IL - Israele	3
LB - Libano	3
NO - Norvegia	3
PK - Pakistan	3
TT - Trinidad e Tobago	3
AZ - Azerbaigian	2
BH - Bahrain	2
CR - Costa Rica	2
CZ - Repubblica Ceca	2
EU - Europa	2
GT - Guatemala	2
IR - Iran	2
KR - Corea	2
RS - Serbia	2
RW - Ruanda	2
UY - Uruguay	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
BG - Bulgaria	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
DK - Danimarca	1
EE - Estonia	1
ET - Etiopia	1
GE - Georgia	1
GY - Guiana	1
HN - Honduras	1
IM - Isola di Man	1
KZ - Kazakistan	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PY - Paraguay	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TO - Tonga	1
UZ - Uzbekistan	1
Totale	10.279

Salva come PNG Salva come JPEG

Città	#
Milan	1.394
Singapore	641
Hong Kong	495
Dallas	447
Ashburn	418
Chicago	281
Beijing	216
Boardman	213
London	174
Dublin	150
Los Angeles	144
Fairfield	141
Rome	119
The Dalles	100
Chandler	94
Varese	92
Seattle	79
Jacksonville	72
Munich	71
New York	63
Como	60
Houston	58
Santa Clara	55
Woodbridge	55
Salt Lake City	53
Wilmington	52
Ogden	49
Washington	43
Brooklyn	42
Ann Arbor	41
Toronto	38
Nyköping	35
Tokyo	34
Cambridge	32
Tampa	32
Warsaw	32
Princeton	30
São Paulo	30
Chennai	29
Frankfurt am Main	29
Vienna	29
Mexico City	27
Izmir	26
Magnago	26
Helsinki	25
Ho Chi Minh City	24
Lancaster	24
Dearborn	23
Denver	22
Nuremberg	22
Boston	21
Elk Grove Village	21
Montreal	20
Council Bluffs	19
Phoenix	19
San Francisco	19
Johannesburg	18
Brussels	17
Hanoi	17
San Diego	17
Atlanta	16
West Jordan	16
Buffalo	15
Orem	15
Rio de Janeiro	15
Belo Horizonte	13
Lappeenranta	13
Poplar	13
Amsterdam	12
Assago	12
Stockholm	12
Turku	12
Ankara	11
Pune	11
Sterling	11
Dulles	9
Düsseldorf	9
Mumbai	9
Charlotte	8
Detroit	8
Dhaka	8
Dong Ket	8
Vancouver	8
Verona	8
Berlin	7
Falkenstein	7
Manchester	7
New Delhi	7
Ottawa	7
Pittsburgh	7
Shanghai	7
Brasília	6
Curitiba	6
Hounslow	6
Porto Alegre	6
São José do Rio Preto	6
Campinas	5
Chiswick	5
Formosa	5
Fort Wayne	5
Totale	7.040

Salva come PNG Salva come JPEG

Nome	#
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	431
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	178
Coronaviridae and SARS-associated coronavirus strain HSR1.	171
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	164
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	164
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	155
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	148
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	144
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	141
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	137
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	123
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	115
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	109
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	108
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	108
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	106
Phage display for the production of human monoclonal antibodies against human pathogens.	99
Humoral immune response against hepatitis C virus.	97
A biologically-validated HCV E1E2 heterodimer structural model	95
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	93
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	87
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	86
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	84
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	82
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	81
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	81
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	78
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	76
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	76
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	73
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	72
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	71
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	71
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	70
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	69
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	69
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	69
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	68
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	67
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	67
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	65
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	65
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	65
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	64
Answer to photo quiz: Streptococcus pneumoniae	63
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	62
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	62
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	61
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	61
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	61
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	61
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	61
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	61
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	60
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	60
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	60
Viral respiratory pathogens and lung Injury	60
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	59
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	58
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	58
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	58
The interferon landscape along the respiratory tract impacts the severity of COVID-19	57
A closer look at prion strains: characterization and important implications	56
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	56
Type III interferons disrupt the lung epithelial barrier upon viral recognition	56
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	56
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	56
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	55
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	55
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	55
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	55
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	54
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	53
Risks of "blind" automated identification systems in medical microbiology	53
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	53
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	53
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	53
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	53
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2	53
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	52
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	52
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	52
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	52
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	52
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	51
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	51
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	50
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis	50
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	49
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	49
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	49
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	49
Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection	49
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	48
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	48
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	48
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	48
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	47
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro	47
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	47
Totale	7.690

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	65.077
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	65.077

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	131	0	0	0	0	0	20	18	17	29	6	16	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	3.196	594	409	616	987	541	49	0	0	0	0	0	0
Totale													10.768